rs112847445
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PM2
The NM_015459.5(ATL3):c.1501G>T(p.Gly501*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_015459.5 stop_gained
Scores
Clinical Significance
Conservation
Publications
- neuropathy, hereditary sensory, type 1FInheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen
- hereditary sensory and autonomic neuropathy type 1Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| ATL3 | ENST00000398868.8 | c.1501G>T | p.Gly501* | stop_gained | Exon 12 of 13 | 1 | NM_015459.5 | ENSP00000381844.3 | ||
| ATL3 | ENST00000538786.1 | c.1447G>T | p.Gly483* | stop_gained | Exon 12 of 13 | 2 | ENSP00000437593.1 | |||
| ENSG00000256789 | ENST00000540307.2 | n.121-6413C>A | intron_variant | Intron 1 of 3 | 3 | 
Frequencies
GnomAD3 genomes  
GnomAD4 exome Cov.: 32 
GnomAD4 genome  
ClinVar
Submissions by phenotype
Neuropathy, hereditary sensory, type 1F    Uncertain:1 
This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Gly501*) in the ATL3 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 41 amino acid(s) of the ATL3 protein. This variant has not been reported in the literature in individuals affected with ATL3-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at